337 related articles for article (PubMed ID: 22185226)
21. Osteoprotegerin Polymorphisms in a Mexican Population with Rheumatoid Arthritis and Generalized Osteoporosis: A Preliminary Report.
Zavala-Cerna MG; Moran-Moguel MC; Cornejo-Toledo JA; Gonzalez-Montoya NG; Sanchez-Corona J; Salazar-Paramo M; Nava-Zavala AH; Aguilar-Chavez EA; Alcaraz-Lopez MF; Gonzalez-Sanchez AG; Gonzalez-Lopez L; Gamez-Nava JI
J Immunol Res; 2015; 2015():376197. PubMed ID: 26065000
[TBL] [Abstract][Full Text] [Related]
22. RANKL and OPG Polymorphisms Are Associated with Aromatase Inhibitor-Related Musculoskeletal Adverse Events in Chinese Han Breast Cancer Patients.
Wang J; Lu K; Song Y; Zhao S; Ma W; Xuan Q; Tang D; Zhao H; Liu L; Zhang Q
PLoS One; 2015; 10(7):e0133964. PubMed ID: 26218592
[TBL] [Abstract][Full Text] [Related]
23. Polymorphisms in genes in the RANKL/RANK/OPG pathway are associated with bone mineral density at different skeletal sites in post-menopausal women.
Tu P; Duan P; Zhang RS; Xu DB; Wang Y; Wu HP; Liu YH; Si L
Osteoporos Int; 2015 Jan; 26(1):179-85. PubMed ID: 25138264
[TBL] [Abstract][Full Text] [Related]
24. Variation in genes involved in the RANKL/RANK/OPG bone remodeling pathway are associated with bone mineral density at different skeletal sites in men.
Hsu YH; Niu T; Terwedow HA; Xu X; Feng Y; Li Z; Brain JD; Rosen CJ; Laird N; Xu X
Hum Genet; 2006 Jan; 118(5):568-77. PubMed ID: 16249885
[TBL] [Abstract][Full Text] [Related]
25. Allelic variations of RANKL/OPG signaling system are related to bone mineral density and in vivo gene expression.
Takács I; Lazáry A; Kósa JP; Kiss J; Balla B; Nagy Z; Bácsi K; Speer G; Lakatos P
Eur J Endocrinol; 2010 Feb; 162(2):423-31. PubMed ID: 19934266
[TBL] [Abstract][Full Text] [Related]
26. Association of the A1330V and V667M polymorphisms of LRP5 with bone mineral density in Greek peri- and postmenopausal women.
Markatseli AE; Hatzi E; Bouba I; Georgiou I; Challa A; Tigas S; Tsatsoulis A
Maturitas; 2011 Oct; 70(2):188-93. PubMed ID: 21840657
[TBL] [Abstract][Full Text] [Related]
27. Association between osteoprotegerin gene polymorphism and bone mineral density in patients with adolescent idiopathic scoliosis.
Eun IS; Park WW; Suh KT; Kim JI; Lee JS
Eur Spine J; 2009 Dec; 18(12):1936-40. PubMed ID: 19705167
[TBL] [Abstract][Full Text] [Related]
28. Skeletal changes in osteoprotegerin and receptor activator of nuclear factor-kappab ligand mRNA levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism.
Stilgren LS; Rettmer E; Eriksen EF; Hegedüs L; Beck-Nielsen H; Abrahamsen B
Bone; 2004 Jul; 35(1):256-65. PubMed ID: 15207766
[TBL] [Abstract][Full Text] [Related]
29. The influence of Lys3Asn polymorphism in the osteoprotegerin gene on bone mineral density in Chinese postmenopausal women.
Zhao HY; Liu JM; Ning G; Zhao YJ; Zhang LZ; Sun LH; Xu MY; Uitterlinden AG; Chen JL
Osteoporos Int; 2005 Dec; 16(12):1519-24. PubMed ID: 15782282
[TBL] [Abstract][Full Text] [Related]
30. Genetic polymorphisms of OPG, RANK, and ESR1 and bone mineral density in Korean postmenopausal women.
Choi JY; Shin A; Park SK; Chung HW; Cho SI; Shin CS; Kim H; Lee KM; Lee KH; Kang C; Cho DY; Kang D
Calcif Tissue Int; 2005 Sep; 77(3):152-9. PubMed ID: 16151677
[TBL] [Abstract][Full Text] [Related]
31. The threshold of bone mineral density for vertebral fractures in female patients with primary hyperparathyroidism.
Kaji H; Yamauchi M; Chihara K; Sugimoto T
Eur J Endocrinol; 2005 Sep; 153(3):373-8. PubMed ID: 16131599
[TBL] [Abstract][Full Text] [Related]
32. The association between RANKL and Osteoprotegerin gene polymorphisms with breast cancer.
Omar HS; Shaker OG; Nassar YH; Marzouk SA; ElMarzouky MS
Mol Cell Biochem; 2015 May; 403(1-2):219-29. PubMed ID: 25724681
[TBL] [Abstract][Full Text] [Related]
33. The association between RANK, RANKL and OPG gene polymorphisms and the risk of rheumatoid arthritis: a case-controlled study and meta-analysis.
Yang H; Liu W; Zhou X; Rui H; Zhang H; Liu R
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31209146
[TBL] [Abstract][Full Text] [Related]
34. Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis.
Tsentidis C; Gourgiotis D; Kossiva L; Doulgeraki A; Marmarinos A; Galli-Tsinopoulou A; Karavanaki K
Osteoporos Int; 2016 Apr; 27(4):1631-1643. PubMed ID: 26588909
[TBL] [Abstract][Full Text] [Related]
35. [Polymorphism of osteoprotegerin gene and osteoporosis in postmenopausal women].
Seremak-Mrozikiewicz A; Tatuśko J; Drews K; Barlik M; Krajewski P; Spaczyński M; Mrozikiewicz PM
Ginekol Pol; 2009 May; 80(5):354-60. PubMed ID: 19548455
[TBL] [Abstract][Full Text] [Related]
36. The effects of osteoprotegerin (OPG) gene polymorphism in patients with ischaemic heart disease on the morphology of coronary arteries and bone mineral density.
Celczyńska Bajew L; Horst Sikorska W; Bychowiec B; Wykrętowicz A; Wesoły J; Michalak M
Kardiol Pol; 2011; 69(6):573-8. PubMed ID: 21678294
[TBL] [Abstract][Full Text] [Related]
37. Parathyroid hormone gene polymorphisms in primary hyperparathyroidism.
Kanzawa M; Sugimoto T; Kobayashi T; Kobayashi A; Chihara K
Clin Endocrinol (Oxf); 1999 May; 50(5):583-8. PubMed ID: 10468923
[TBL] [Abstract][Full Text] [Related]
38. Gene Polymorphisms in the RANKL/RANK/OPG Pathway Are Associated with Type 2 Diabetes Mellitus in Southern Han Chinese Women.
Duan P; Tu P; Si L; Hu W; Liu M; Liu J; Xue Y
Genet Test Mol Biomarkers; 2016 Jun; 20(6):285-90. PubMed ID: 27171030
[TBL] [Abstract][Full Text] [Related]
39. Investigation of OPG/RANK/RANKL Genes as a Genetic Marker for Cardiac abnormalities in Thalassemia Major Patients.
Singh MM; Kumar R; Tewari S; Agarwal S
Ann Hum Genet; 2017 May; 81(3):117-124. PubMed ID: 28244588
[TBL] [Abstract][Full Text] [Related]
40. Association of the 163A/G and 1181G/C osteoprotegerin polymorphism with bone mineral density.
García-Unzueta MT; Riancho JA; Zarrabeitia MT; Sañudo C; Berja A; Valero C; Pesquera C; Paule B; González-Macías J; Amado JA
Horm Metab Res; 2008 Mar; 40(3):219-24. PubMed ID: 18348083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
